Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Rheumatoid Arthritis

Free Subscription Articles published in Clin Exp Rheumatol Retrieve available abstracts of 225 articles: HTML format

Single Articles

September 2023
1. PISANI F, Croia C, Petrelli F, Chericoni E, et al
   The multifaceted role of mast cells in the pathogenesis of rheumatoid arthritis.
   Clin Exp Rheumatol. 2023 Sep 7. doi: 10.55563.
   PubMed     Abstract available
   
   
   
2. PEDERSEN TT, Fenstad MH, Wallenius M, Hetlelid E, et al
   Low serum lipocalin-2 in pregnant women with systemic lupus erythematosus.
   Clin Exp Rheumatol. 2023;41:1838-1846.
   PubMed     Abstract available
   
   
   August 2023
3. KARADAG O, Farisogullari B, Yagiz B, Erden A, et al
   Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry.
   Clin Exp Rheumatol. 2023 Aug 29. doi: 10.55563.
   PubMed     Abstract available
   
   
   
4. YANG W, Zhang Q, Liu J, Xu Y, et al
   The association of serum uric acid with all-cause and cardiovascular mortality among adults with rheumatoid arthritis: a cohort study.
   Clin Exp Rheumatol. 2023 Aug 28. doi: 10.55563.
   PubMed     Abstract available
   
   
   July 2023
5. MOYSIDOU GS, Marotte H, Kossi S, Tubach F, et al
   Ability to predict rheumatoid arthritis relapse after tumour necrosis factor inhibitor tapering by the Multi-Biomarker Disease Activity Score: a post-hoc analysis of the STRASS trial.
   Clin Exp Rheumatol. 2023 Jul 24. doi: 10.55563.
   PubMed     Abstract available
   
   
   
6. GORODETSKIY V, Sidorova Y, Biderman B, Ryzhikova N, et al
   Prevalence of STAT3 mutations in patients with rheumatoid arthritis-associated T-cell large granular lymphocytic leukaemia and Felty syndrome.
   Clin Exp Rheumatol. 2023 Jul 24. doi: 10.55563.
   PubMed     Abstract available
   
   
   
7. MARIANI FM, Martelli I, Pistone F, Chericoni E, et al
   Pathogenesis of rheumatoid arthritis: one year in review 2023.
   Clin Exp Rheumatol. 2023 Jul 24. doi: 10.55563.
   PubMed     Abstract available
   
   
   
8. GARAFFONI C, Adinolfi A, Bortoluzzi A, Filippou G, et al
   Novel insights into the management of rheumatoid arthritis: one year in review 2023.
   Clin Exp Rheumatol. 2023 Jul 24. doi: 10.55563.
   PubMed     Abstract available
   
   
   
9. MO Q, Wang M, Cai S, Zhong J, et al
   A comparative study on the clinical and magnetic resonance imaging features between seronegative and seropositive rheumatoid arthritis.
   Clin Exp Rheumatol. 2023 Jul 14. doi: 10.55563.
   PubMed     Abstract available
   
   
   
10. BRANDAO M, Fonseca T, Quelhas Costa R, Oliveira JC, et al
    Impact of disease duration on proteomic bioprofile and prognosis in rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2023 Jul 13. doi: 10.55563.
    PubMed     Abstract available
    
    
    
11. BEHRENS F, Burmester GR, Hofmann MW, Aringer M, et al
    Sustained effectiveness and safety of subcutaneous tocilizumab over two years in the ARATA observational study.
    Clin Exp Rheumatol. 2023;41:1463-1472.
    PubMed     Abstract available
    
    
    June 2023
12. AKHAVAN PS, Movahedi M, Cesta A, Bombardier C, et al
    Factors affecting the discrepancy between patient and physician global assessment in early rheumatoid arthritis: The Ontario Best Practices Research Initiative.
    Clin Exp Rheumatol. 2023 Jun 15. doi: 10.55563.
    PubMed     Abstract available
    
    
    
13. HINKEMA HJ, Arends S, Mulder DJ, Westra J, et al
    Higher skin autofluorescence in individuals at risk for rheumatoid arthritis: results from a large population based cohort.
    Clin Exp Rheumatol. 2023 Jun 15. doi: 10.55563.
    PubMed     Abstract available
    
    
    
14. GUARACHA-BASANEZ GA, Contreras-Yanez I, Bautista-Torres LE, Ortiz-Haro AB, et al
    Sleep quality and predictors of optimal sleep in patients with rheumatoid arthritis: data from a recent-onset cohort.
    Clin Exp Rheumatol. 2023 Jun 6. doi: 10.55563.
    PubMed     Abstract available
    
    
    
15. BENACHI SANDOVAL N, Fernandez Sola J, Guaita Mateo A, Navarrete Duran MP, et al
    Design and validation of a predictive model for determining the risk of developing fibromyalgia.
    Clin Exp Rheumatol. 2023;41:1238-1247.
    PubMed     Abstract available
    
    
    May 2023
16. RAINE C, Ciurtin C, Jury EC, Williams DJ, et al
    DAS28(3)CRP is a reliable measure of disease activity in pregnant women with rheumatoid arthritis.
    Clin Exp Rheumatol. 2023 May 18. doi: 10.55563.
    PubMed     Abstract available
    
    
    
17. SALAFFI F, Farah S, Di Carlo M
    Kihon Checklist validation in patients with rheumatoid arthritis: Italian translation, cross-cultural adaptation, and evaluation of the validity in comparison to two frailty screening tools based on the Fried phenotype and deficit accumulation model.
    Clin Exp Rheumatol. 2023 May 15. doi: 10.55563.
    PubMed     Abstract available
    
    
    
18. WEMAN L, Salo H, Kuusalo L, Huhtakangas J, et al
    Disease burden measured by patient-reported outcomes: does psoriatic arthritis feel worse than rheumatoid arthritis? A cross-sectional nationwide study.
    Clin Exp Rheumatol. 2023 May 15. doi: 10.55563.
    PubMed     Abstract available
    
    
    
19. NOVELLA-NAVARRO M, Genre F, Martinez-Feito A, Pulito-Cueto V, et al
    Obesity and adipose tissue cytokines in rheumatoid arthritis treated with IL-6 inhibitors: does the route of administration matter?
    Clin Exp Rheumatol. 2023 May 3. doi: 10.55563.
    PubMed    
    
    
    
20. LUO Z, Liu H, Luo Y, Chen Y, et al
    Acid sphingomyelinase regulates the biological functions of fibroblast-like synoviocytes.
    Clin Exp Rheumatol. 2023;41:1200-1201.
    PubMed    
    
    
    
21. DAMIANI A, Bartoli F, Pacini G, Carboni D, et al
    Persistence of remission after lengthening of golimumab in inflammatory joint diseases.
    Clin Exp Rheumatol. 2023;41:1088-1095.
    PubMed     Abstract available
    
    
    April 2023
22. MIN HK, Kim SH, Lee JY, Lee SH, et al
    Interleukin-18 binding protein regulates the apoptosis and necroptosis of fibroblast-like synoviocytes and chondrocytes in rheumatoid arthritis.
    Clin Exp Rheumatol. 2023 Apr 13. doi: 10.55563.
    PubMed     Abstract available
    
    
    March 2023
23. CHEN Z, Cheng Z, Tang Z, Li M, et al
    Interleukin-13 reduces bone erosion in rheumatoid arthritis by up-regulating osteoprotegerin expression in fibroblast-like synoviocytes : an in vitro and in vivo study.
    Clin Exp Rheumatol. 2023 Mar 27. doi: 10.55563.
    PubMed     Abstract available
    
    
    
24. CHEN Q, Geng Q, Yu X, Lu F, et al
    High-throughput RNA-sequencing reveals novel targets of tofacitinib in the treatment of rheumatoid arthritis.
    Clin Exp Rheumatol. 2023 Mar 27. doi: 10.55563.
    PubMed     Abstract available
    
    
    
25. AHN SS, Han M, Jung I, Kim HW, et al
    Cancers and cardiovascular diseases in patients with seropositive rheumatoid arthritis treated with JAK inhibitors, biologics and conventional synthetic DMARDs.
    Clin Exp Rheumatol. 2023 Mar 27. doi: 10.55563.
    PubMed     Abstract available
    
    
    
26. MASIC D, Stengaard-Pedersen K, Bridal Logstrup B, Horslev-Petersen K, et al
    Plasma levels of multiple cardiovascular- and inflammation-related proteins analysed for associations with disease activity and anti-cyclic citrullinated peptide status in active early rheumatoid arthritis.
    Clin Exp Rheumatol. 2023 Mar 16. doi: 10.55563.
    PubMed     Abstract available
    
    
    
27. MOHAMED AHAMADA M, Wu X
    Analysis of efficacy and safety of abatacept for rheumatoid arthritis: systematic review and meta-analysis.
    Clin Exp Rheumatol. 2023 Mar 7. doi: 10.55563.
    PubMed     Abstract available
    
    
    
28. CACCIAPAGLIA F, Spinelli FR, Erre GL, Gremese E, et al
    Italian recommendations for the assessment of cardiovascular risk in rheumatoid arthritis: a position paper of the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group of the Italian Society of Rheumatology.
    Clin Exp Rheumatol. 2023 Mar 2. doi: 10.55563.
    PubMed     Abstract available
    
    
    
29. GERTEL S, Polachek A, Furer V, Paran D, et al
    Synovial monocytes from psoriatic and rheumatoid arthritis patients are modulated differently by TNF inhibitors and glucocorticoids: an ex-vivo study.
    Clin Exp Rheumatol. 2023 Mar 2. doi: 10.55563.
    PubMed     Abstract available
    
    
    
30. DE STEFANO L, D'Onofrio B, Gandolfo S, Bozzalla Cassione E, et al
    Seronegative rheumatoid arthritis: one year in review 2023.
    Clin Exp Rheumatol. 2023;41:554-564.
    PubMed     Abstract available
    
    
    
31. DE STEFANO L, Balduzzi S, Bogliolo L, D'Onofrio B, et al
    Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs.
    Clin Exp Rheumatol. 2023;41:667-675.
    PubMed     Abstract available
    
    
    
32. DAOOD R, Toledano K, Markovits D, Tavor Y, et al
    Switching from intravenous tocilizumab to subcutaneous administration during COVID-19 pandemic: impact on treatment efficacy and patient satisfaction.
    Clin Exp Rheumatol. 2023;41:744-746.
    PubMed     Abstract available
    
    
    
33. GASPAROTTO M, Bindoli S, Padoan R, Cozzi G, et al
    New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort.
    Clin Exp Rheumatol. 2023;41:642-648.
    PubMed     Abstract available
    
    
    
34. SCRIVO R, Castellani C, Mancuso S, Sciarra G, et al
    Effectiveness of non-medical switch from adalimumab bio-originator to SB5 biosimilar and from ABP501 adalimumab biosimilar to SB5 biosimilar in patients with chronic inflammatory arthropathies: a monocentric observational study.
    Clin Exp Rheumatol. 2023;41:613-619.
    PubMed     Abstract available
    
    
    
35. VOGLER D, Ruscitti P, Navarini L, Giacomelli R, et al
    Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres.
    Clin Exp Rheumatol. 2023;41:656-666.
    PubMed     Abstract available
    
    
    February 2023
36. YAMAZAKI K, Kiyomi A, Imai S, Sugiyama K, et al
    Effect of prednisolone and saireito co-administration on T-cells of rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2023 Feb 24. doi: 10.55563.
    PubMed     Abstract available
    
    
    
37. PENG W, Wu S, Wang W
    Correlation of serum citrullinated histone H3 levels with disease activity in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2023 Feb 23. doi: 10.55563.
    PubMed     Abstract available
    
    
    January 2023
38. ALMEIDA-SANTIAGO C, Quevedo-Abeledo JC, Hernandez-Hernandez V, de Vera-Gonzalez A, et al
    Circulating interleukin-6 and cardiovascular disease risk in patients with rheumatoid arthritis with low disease activity due to active therapy.
    Clin Exp Rheumatol. 2023 Jan 31. doi: 10.55563.
    PubMed     Abstract available
    
    
    
39. KOHNO H, Sugimoto T, Yoshida Y, Mokuda S, et al
    Association between increased serum IL-23 levels and ACPA positivity in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2023 Jan 31. doi: 10.55563.
    PubMed    
    
    
    
40. ANYFANTI P, Gavriilaki E, Dolgyras P, Nikolaidou B, et al
    Skin microcirculation dynamics are impaired in patients with rheumatoid arthritis and no cardiovascular comorbidities.
    Clin Exp Rheumatol. 2023 Jan 26. doi: 10.55563.
    PubMed     Abstract available
    
    
    
41. SANNA GD, Piga M, Piga A, Falco O, et al
    Prevalence and clinical significance of electrocardiographic signs of atrial myopathy in rheumatoid arthritis: results from the EDRA study.
    Clin Exp Rheumatol. 2023 Jan 2. doi: 10.55563.
    PubMed     Abstract available
    
    
    
42. OUATAH H, Authier N, Tournadre A, Fan A, et al
    Frequency of cannabis use in patients with rheumatoid arthritis or spondyloarthropathies: a single-centre study.
    Clin Exp Rheumatol. 2023;41:198.
    PubMed    
    
    
    December 2022
43. SAITO S, Suzuki K, Yoshimoto K, Kondo Y, et al
    Differences in the strength of inhibition of interleukin-6 signalling by subcutaneous sarilumab and tocilizumab in rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2022 Dec 15. doi: 10.55563.
    PubMed     Abstract available
    
    
    
44. HILLIQUIN S, Herrou J, Guterman L, Goulvestre C, et al
    Changes of anti-citrullinated peptide antibodies titers after biologic treatment in patients with rheumatoid arthritis: a systematic literature review and retrospective study.
    Clin Exp Rheumatol. 2022 Dec 7. doi: 10.55563.
    PubMed     Abstract available
    
    
    
45. YANG W, Xu Y, Lin J, Liu J, et al
    Global, regional and national burden of rheumatoid arthritis, and attributable risk factors from 1990 to 2019: update from the Global Burden of Disease 2019 study.
    Clin Exp Rheumatol. 2022 Dec 5. doi: 10.55563.
    PubMed     Abstract available
    
    
    
46. CARLOTTI E, Murray-Brown W, Blighe K, Caliste M, et al
    High-throughput sequencing of IgH gene in minor salivary glands from Sjogren's syndrome patients reveals dynamic B cell recirculation between ectopic lymphoid structures.
    Clin Exp Rheumatol. 2022;40:2363-2372.
    PubMed     Abstract available
    
    
    
47. FULVIO G, Donati V, Izzetti R, Fonzetti S, et al
    Correspondence between minor salivary glands ultra-high frequency ultrasonography and histology: a case report of severe/atypical lymphoid infiltrate in Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2474-2475.
    PubMed    
    
    
    
48. STERGIOU IE, Chatzis LG, Pezoulas VC, Baldini C, et al
    The clinical phenotype of primary Sjogren's syndrome patients with lymphadenopathy.
    Clin Exp Rheumatol. 2022;40:2357-2362.
    PubMed     Abstract available
    
    
    
49. MANFRE V, Chatzis LG, Cafaro G, Fonzetti S, et al
    Sjogren's syndrome: one year in review 2022.
    Clin Exp Rheumatol. 2022;40:2211-2224.
    PubMed     Abstract available
    
    
    
50. PRIORI R, Giardina F, Gioia C, Iannuccelli C, et al
    Cultural adaptation and preliminary validation of the Qualisex questionnaire for its use in patients with Sjogren's syndrome and fibromyalgia in Italy.
    Clin Exp Rheumatol. 2022;40:2470-2471.
    PubMed    
    
    
    
51. FLORES-CHAVEZ A, Ng WF, Alunno A, Inanc N, et al
    Characterisation of the coexistence between sarcoidosis and Sjogren's syndrome. Analysis of 43 patients.
    Clin Exp Rheumatol. 2022;40:2329-2337.
    PubMed     Abstract available
    
    
    
52. LA ROCCA G, Ferro F, Bulleri A, Fulvio G, et al
    Glandular involvement in primary Sjogren's syndrome patients with interstitial lung disease-onset and sicca-onset, a single centre cross-sectional study.
    Clin Exp Rheumatol. 2022;40:2344-2349.
    PubMed     Abstract available
    
    
    
53. DE WOLFF L, Vissink A, van Nimwegen JF, van Zuiden G, et al
    Patient Acceptable Symptom State (PASS) in patients with primary Sjogren's syndrome in daily clinical practice.
    Clin Exp Rheumatol. 2022;40:2303-2309.
    PubMed     Abstract available
    
    
    
54. INANC N, Kostov B, Priori R, Flores-Chavez A, et al
    Safety and efficacy of SARS-CoV-2 vaccination in 1237 patients with primary Sjogren syndrome.
    Clin Exp Rheumatol. 2022;40:2290-2297.
    PubMed     Abstract available
    
    
    
55. ZABOTTI A, Pegolo E, Giovannini I, Manfre V, et al
    Usefulness of ultrasound guided core needle biopsy of the parotid gland for the diagnosis of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2381-2386.
    PubMed     Abstract available
    
    
    
56. LUO J, Zhang Y, Chen JQ, Song WJ, et al
    Distinct clinical phenotypes of primary Sjogren's syndrome differ by onset age: a retrospective study of 742 cases and review of the literature.
    Clin Exp Rheumatol. 2022;40:2373-2380.
    PubMed     Abstract available
    
    
    
57. SILVERIO-ANTONIO M, Alves Ribeiro L, Medeiros J, Fonseca JE, et al
    Sjogren's syndrome presenting as thrombotic thrombocytopenic purpura in a male patient with previous Kikuchi-Fujimoto disease.
    Clin Exp Rheumatol. 2022;40:2472-2473.
    PubMed    
    
    
    
58. BELLOS S, Velonakis G, Anagnostouli M, Mavragani CP, et al
    Posterior reversible encephalopathy syndrome in a patient with anticentromere positive Sjogren's syndrome/mixed connective tissue disease overlap: a case report and review of the literature.
    Clin Exp Rheumatol. 2022;40:2468-2469.
    PubMed    
    
    
    
59. YANG T, Delli K, Coumou AD, van der Vegt B, et al
    The lacrimal gland in Sjogren's syndrome: can we unravel its mystery using ultrasound?
    Clin Exp Rheumatol. 2022;40:2428-2433.
    PubMed     Abstract available
    
    
    
60. KAKLAMANOS A, Goules AV, Tzioufas AG
    Experimental models of Sjogren's syndrome: differences and similarities with human disease.
    Clin Exp Rheumatol. 2022;40:2398-2412.
    PubMed     Abstract available
    
    
    
61. ARENDS S, de Wolff L, Deroo L, Verstappen GM, et al
    Selection of study endpoints and patients for clinical trials in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2225-2232.
    PubMed     Abstract available
    
    
    
62. DELLI K, van Ginkel MS, Vissink A, Stel AJ, et al
    Can salivary gland ultrasonography replace salivary gland biopsy in the diagnosis of Sjogren's syndrome?
    Clin Exp Rheumatol. 2022;40:2443-2449.
    PubMed     Abstract available
    
    
    
63. WANG X, Wang A, Zhan X, Xu L, et al
    Value of conventional ultrasound and shear wave elastography in assessing disease activity and prognosis in female patients with Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2350-2356.
    PubMed     Abstract available
    
    
    
64. PRAK RF, Arends S, Verstappen GM, van Zuiden G, et al
    Fatigue in primary Sjogren's syndrome is associated with an objective decline in physical performance, pain and depression.
    Clin Exp Rheumatol. 2022;40:2318-2328.
    PubMed     Abstract available
    
    
    
65. CORDEIRO RA, de Oliveira JL, Ferraciolli SF, Guedes LKN, et al
    Neurosarcoidosis during the treatment of primary Sjogren's syndrome: is it a paradoxical effect of rituximab?
    Clin Exp Rheumatol. 2022;40:2464-2465.
    PubMed    
    
    
    
66. DE VITA S, Zabotti A, Tommasini A, Dorner T, et al
    The importance of studying the parotid glands in primary Sjogren's syndrome: the right tissue at the right time.
    Clin Exp Rheumatol. 2022;40:2233-2236.
    PubMed    
    
    
    
67. CERESER L, Giovannini I, Caronia G, Zabotti A, et al
    Chest high-resolution computed tomography in primary Sjogren's syndrome: an up-to-date primer for rheumatologists.
    Clin Exp Rheumatol. 2022;40:2450-2462.
    PubMed     Abstract available
    
    
    
68. WITTE T, Engelke F, Ritter J, Dorner T, et al
    Towards the identification of novel autoantibodies in Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2395-2397.
    PubMed     Abstract available
    
    
    
69. GOULES AV, Pringle S, Ramos-Casals M, Tzioufas AG, et al
    Pathophysiology of Sjogren's-like syndrome induced by cancer immunotherapies: similarities and differences with classical Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2237-2239.
    PubMed    
    
    
    
70. PRINGLE S, Verstappen GM, van Ginkel MS, Nakshbandi U, et al
    Lymphoepithelial lesions in the salivary glands of primary Sjogren's syndrome patients: the perfect storm?
    Clin Exp Rheumatol. 2022;40:2434-2442.
    PubMed     Abstract available
    
    
    
71. BRITO-ZERON P, Retamozo S, Flores-Chavez A, Akasbi M, et al
    Practical diagnostic tips for the Sjogren Clinic: pearls, myths and mistakes.
    Clin Exp Rheumatol. 2022;40:2413-2427.
    PubMed     Abstract available
    
    
    
72. CAFARO G, Perricone C, Bursi R, Riccucci I, et al
    Ultrasound scoring systems affect the distribution of sialadenitis scores in Sjogren's syndrome: an inter-system reproducibility study.
    Clin Exp Rheumatol. 2022;40:2253-2257.
    PubMed     Abstract available
    
    
    
73. DEROO L, Achten H, De Boeck K, Genbrugge E, et al
    The value of separate detection of anti-Ro52, anti-Ro60 and anti-SSB/La reactivities in relation to diagnosis and phenotypes in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2310-1317.
    PubMed     Abstract available
    
    
    
74. CHATZIS LG, Koulouri V, Baldini C, Pezoulas VC, et al
    Clinical and laboratory findings of primary Sjogren's syndrome patients without sicca symptoms.
    Clin Exp Rheumatol. 2022;40:2298-2302.
    PubMed     Abstract available
    
    
    
75. AMEZCUA-GUERRA LM, Sanchez-Munoz F, Pichardo-Ontiveros E, Gonzalez-Ramirez J, et al
    Interferon-alpha regulates expression of lncRNA MALAT1 and interferon-stimulated genes, as well as chemokine production, in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2275-2282.
    PubMed     Abstract available
    
    
    
76. MARTINS VAO, Floriano TF, Leon EP, Villamarin LEB, et al
    Primary dental care treatment in primary Sjogren's syndrome: a possible role in improving salivary flow rate.
    Clin Exp Rheumatol. 2022;40:2258-2267.
    PubMed     Abstract available
    
    
    
77. XU R, Yan Q, Gong Y, Cai CS, et al
    Tacrolimus therapy in primary Sjogren's syndrome with refractory immune thrombocytopenia: a retrospective study.
    Clin Exp Rheumatol. 2022;40:2268-2274.
    PubMed     Abstract available
    
    
    
78. KIM SH, Min HK, Lee SH, Lee KA, et al
    Ultrasonographic evaluation of lacrimal glands in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2283-2289.
    PubMed     Abstract available
    
    
    
79. STEINMETZ TD, de Wolff L, Terpstra JH, Visser A, et al
    Immunisation with Coronavirus-2 vaccines induces potent antibody responses and does not aggravate the lymphocyte compartment of primary Sjogren's syndrome patients.
    Clin Exp Rheumatol. 2022;40:2338-2343.
    PubMed     Abstract available
    
    
    
80. TAKAGI Y, Hashimoto K, Sasaki M, Eida S, et al
    Juvenile onset of primary Sjogren's syndrome: changes in imaging findings during a 7-year progression.
    Clin Exp Rheumatol. 2022;40:2466-2467.
    PubMed    
    
    
    
81. HE J, Jiang J, Baumgart K
    Candidate autoantibodies for primary Sjogren's syndrome: where are they now?
    Clin Exp Rheumatol. 2022;40:2387-2394.
    PubMed     Abstract available
    
    
    
82. LUO J, Song WJ, Chen JQ, Yang GY, et al
    Factors associated with secondary immune thrombocytopenia in patients with primary Sjogren's syndrome: a retrospective study of 639 cases.
    Clin Exp Rheumatol. 2022;40:2245-2252.
    PubMed     Abstract available
    
    
    
83. CRUZ-BAUTISTA I, Almeda-Valdes P, Lopez-Carrasco G, Astudillo M, et al
    Total body water and sicca symptoms in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2240-2244.
    PubMed     Abstract available
    
    
    November 2022
84. GERMONPRE S, Mulier S, Falzon L, Boonen A, et al
    Prevalence of frailty and pre-frailty in patients with rheumatoid arthritis: a systematic literature review and meta-analysis.
    Clin Exp Rheumatol. 2022 Nov 24. doi: 10.55563.
    PubMed     Abstract available
    
    
    
85. DE SOUZA FFL, Schneider AH, Machado CC, de Almeida SCL, et al
    Synovial fluid survivin and NETs as independent biomarkers in rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Nov 24. doi: 10.55563.
    PubMed     Abstract available
    
    
    
86. WAJDA A, Stypinska B, Czarnecka M, Hasan D, et al
    Are SMAD2/4/7 genetic variants associated with rheumatoid arthritis susceptibility and severity?
    Clin Exp Rheumatol. 2022 Nov 13. pii: 18825.
    PubMed     Abstract available
    
    
    
87. NOVELLA-NAVARRO M, Ruiz-Esquide V, Torres-Ortiz G, Chacur CA, et al
    A paradigm of difficult-to-treat rheumatoid arthritis: subtypes and early identification.
    Clin Exp Rheumatol. 2022 Nov 13. pii: 18765.
    PubMed     Abstract available
    
    
    
88. VITTECOQ O, Kozyreff-Meurice M, Houivet E, Leon N, et al
    Clinical and ultrasonographic evaluation of the window of opportunity for retreatment with rituximab in rheumatoid arthritis patients from a multicentre real-life study.
    Clin Exp Rheumatol. 2022 Nov 12. pii: 18669.
    PubMed     Abstract available
    
    
    
89. BEN-CHETRIT E, Ben-Chetrit E
    Reply to comment on: Palindromic rheumatism following COVID-19 infection evolved to rheumatoid arthritis after COVID-19 reinfection.
    Clin Exp Rheumatol. 2022;40:2201.
    PubMed    
    
    
    
90. ANDREICA I, Jast R, Rezniczek GA, Kiefer D, et al
    Changes of immunosuppressive medication because of COVID-19 by patients with chronic inflammatory rheumatic diseases: anxiety was not a major driver.
    Clin Exp Rheumatol. 2022;40:2044-2051.
    PubMed     Abstract available
    
    
    October 2022
91. ZHANG X, Wang H, Song X, Song Y, et al
    Compound 78c exerts a therapeutic effect on collagen-induced arthritis and rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Oct 29. pii: 18748.
    PubMed     Abstract available
    
    
    
92. TANAKA Y, Takahashi T, Van Hoogstraten H, Praestgaard A, et al
    Haemoglobin changes and disease activity in Japanese patients with rheumatoid arthritis treated with sarilumab.
    Clin Exp Rheumatol. 2022 Oct 28. pii: 18235.
    PubMed     Abstract available
    
    
    
93. CHANG CK, Chang KH, Cheng WC, Chen PK, et al
    Lipid metabolomic signature might predict subclinical atherosclerosis in patients with active rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Oct 4. pii: 18824.
    PubMed     Abstract available
    
    
    
94. JEONG E, Jung JY, Lee MJ, Kim HA, et al
    A link between CD8+CD27-CD28- T cells expressing chemerin chemokine-like receptor 1 and rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Oct 4. pii: 18772.
    PubMed     Abstract available
    
    
    September 2022
95. DING JT, Hong FF, Yang SL
    Roles of autophagy in rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Sep 22. pii: 18442.
    PubMed     Abstract available
    
    
    
96. YAVROPOULOU MP, Filippa MG, Panopoulos S, Spanos E, et al
    Impaired adrenal cortex reserve in patients with rheumatic and musculoskeletal diseases who relapse upon tapering of low glucocorticoid dose.
    Clin Exp Rheumatol. 2022;40:1789-1792.
    PubMed     Abstract available
    
    
    
97. YANG H, Luo Y, Lai X
    Il-34 regulates MAPKs, PI3K/Akt, JAK and NF-kappaB pathways and induces the expression of inflammatory factors in RA-FLS.
    Clin Exp Rheumatol. 2022;40:1779-1788.
    PubMed     Abstract available
    
    
    
98. WESTON S, Macdonald JL, Williams LM, Roussou E, et al
    The JAK inhibitor baricitinib inhibits oncostatin M induction of proinflammatory mediators in ex-vivo synovial derived cells.
    Clin Exp Rheumatol. 2022;40:1620-1628.
    PubMed     Abstract available
    
    
    August 2022
99. LEE JY, Kim SH, Lee SH, Kim HR, et al
    Effect of Janus kinase inhibitors on T cell responses to herpes zoster in rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2022 Aug 31. pii: 18678.
    PubMed     Abstract available
    
    
    
100. JUNG JY, Lee E, Kim JW, Suh CH, et al
     Efficacy and drug retention of tofacitinib in rheumatoid arthritis: from the nationwide Korean College of Rheumatology Biologics registry.
     Clin Exp Rheumatol. 2022 Aug 31. pii: 18570.
     PubMed     Abstract available
     
     
     
101. DUARTE C, Santos E, Barreira SC, Avila-Ribeiro P, et al
     Can numerical rating scales of disease impact be used as targets for patient-centred management in rheumatoid arthritis?
     Clin Exp Rheumatol. 2022 Aug 5. pii: 18562.
     PubMed     Abstract available
     
     
     
102. KOUKI I, Sacco I, Eymard F, Fautrel B, et al
     An adult-onset Still's disease during infection with Chlamydia trachomatis.
     Clin Exp Rheumatol. 2022 Aug 1. pii: 18800.
     PubMed    
     
     
     July 2022
103. DROSOS AA, Pelechas E, Venetsanopoulou AI, Voulgari PV, et al
     Comment on: Palindromic rheumatism following COVID-19 infection evolved to rheumatoid arthritis after COVID-19 reinfection.
     Clin Exp Rheumatol. 2022 Jul 26. pii: 18811.
     PubMed    
     
     
     
104. GUELLEC D, Carvajal-Alegria G, Daien C, Gossec L, et al
     Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohort.
     Clin Exp Rheumatol. 2022 Jul 21. pii: 18514.
     PubMed     Abstract available
     
     
     
105. GARAFFONI C, Adinolfi A, Bortoluzzi A, Filippou G, et al
     Novel insights into the management of rheumatoid arthritis: one year in review 2022.
     Clin Exp Rheumatol. 2022;40:1247-1257.
     PubMed     Abstract available
     
     
     
106. PELLEGRINO G, Mancuso S, Colasanti T, Mieli S, et al
     Lack of cross-reactivity between rheumatoid factor IgM and anti-S1 receptor binding domain of SARS-CoV-2 IgM: a case-control study.
     Clin Exp Rheumatol. 2022;40:1417-1419.
     PubMed     Abstract available
     
     
     
107. GALLOWAY J, Raine T, Rivett L, Roberts J, et al
     Herpes zoster and Janus kinase inhibition in rheumatology and gastroenterology patients: managing risk and vaccination.
     Clin Exp Rheumatol. 2022;40:1432-1441.
     PubMed     Abstract available
     
     
     
108. RAVAEI A, Rubini M
     Rescuing effect of folates on methotrexate cytotoxicity in human trophoblast cells.
     Clin Exp Rheumatol. 2022;40:1403-1410.
     PubMed     Abstract available
     
     
     June 2022
109. SAKELLARIOU G, Carrara G, Zanetti A, Scire CA, et al
     Do we need Early Arthritis Clinics to counteract the excess of mortality in rheumatoid arthritis?
     Clin Exp Rheumatol. 2022 Jun 28. pii: 18227.
     PubMed    
     
     
     
110. WEMAN L, Vehmas J, Immonen J, Hannonen P, et al
     Real-world data on seropositive rheumatoid arthritis, then and now: ten-year outcomes of 1151 patients diagnosed between 1997 and 2011.
     Clin Exp Rheumatol. 2022 Jun 28. pii: 18494.
     PubMed     Abstract available
     
     
     
111. LE MOINE C, Soyfoo MS, Mekkaoui L, Dahma H, et al
     Waning humoral immunity of SARS-CoV-2 vaccination in a rheumatoid arthritis cohort and the benefits of a vaccine booster dose.
     Clin Exp Rheumatol. 2022 Jun 13. pii: 18477.
     PubMed     Abstract available
     
     
     
112. GUL HL, Di Matteo A, Mankia K, Wu J, et al
     Can biomarkers predict successful tapering of conventional disease-modifying therapy in rheumatoid arthritis patients in stable remission?
     Clin Exp Rheumatol. 2022 Jun 13. pii: 18334.
     PubMed     Abstract available
     
     
     May 2022
113. LEE H, Chen SK, Gautam N, Vine SM, et al
     Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study.
     Clin Exp Rheumatol. 2022 May 10. pii: 18274.
     PubMed     Abstract available
     
     
     
114. DI COLA I, Di Muzio C, Conforti A, Iacono D, et al
     Adult-onset Still's disease with elderly onset, results from a multicentre study.
     Clin Exp Rheumatol. 2022 May 4. pii: 18230.
     PubMed     Abstract available
     
     
     
115. CECCARELLI F, Spinelli FR, Garufi C, Mancuso S, et al
     The role of musculoskeletal ultrasound in predicting the response to JAK inhibitors: results from a monocentric cohort.
     Clin Exp Rheumatol. 2022;40:921-927.
     PubMed     Abstract available
     
     
     
116. GAUD-LISTRAT V, Lopez-Medina C, Hudry C, Nguyen M, et al
     Adherence to and patient's knowledge of self-management of subcutaneous biologic therapy in chronic inflammatory rheumatic diseases: results of a multicentre cross-sectional study.
     Clin Exp Rheumatol. 2022;40:928-935.
     PubMed     Abstract available
     
     
     
117. BALDINI C, Arnaud L, Avcin T, Beretta L, et al
     Sjogren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison.
     Clin Exp Rheumatol. 2022;40 Suppl 134:103-112.
     PubMed     Abstract available
     
     
     
118. MUCKE J, Cornet A, Witte T, Schneider M, et al
     Association of common variable immunodeficiency and rare and complex connective tissue and musculoskeletal diseases. A systematic literature review.
     Clin Exp Rheumatol. 2022;40 Suppl 134:40-45.
     PubMed     Abstract available
     
     
     
119. PETITDEMANGE A, Sztejkowski C, Damian L, Martin T, et al
     Treatment of relapsing polychondritis: a systematic review.
     Clin Exp Rheumatol. 2022;40 Suppl 134:81-85.
     PubMed     Abstract available
     
     
     April 2022
120. LARSSON C, Andersson KME, Nadali M, Silfversward ST, et al
     MicroRNA and interleukin 6 interplay in the adipose tissue of rheumatoid arthritis patients.
     Clin Exp Rheumatol. 2022 Apr 29. pii: 18013.
     PubMed     Abstract available
     
     
     
121. MARTIN-GONZALEZ C, Martin-Folgueras T, Quevedo-Abeledo JC, de Armas-Rillo L, et al
     Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III.
     Clin Exp Rheumatol. 2022 Apr 6. pii: 18203.
     PubMed     Abstract available
     
     
     March 2022
122. KEYSTONE E, Movahedi M, Cesta A, Bombardier C, et al
     Differential influence of Clinical Disease Activity Index components based on disease state in rheumatoid arthritis patients: real-world results from the Ontario Best Practices Research Initiative.
     Clin Exp Rheumatol. 2022 Mar 30. pii: 17725.
     PubMed     Abstract available
     
     
     
123. LIN T, Xu S, Wang Y, Nian X, et al
     Human epididymis protein 4 as a new diagnostic biomarker for rheumatoid arthritis-associated interstitial lung disease.
     Clin Exp Rheumatol. 2022 Mar 23. pii: 18186.
     PubMed     Abstract available
     
     
     
124. CAMPOCHIARO C, Farina N, Tomelleri A, De Luca G, et al
     Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease.
     Clin Exp Rheumatol. 2022 Mar 18. pii: 17994.
     PubMed    
     
     
     
125. KLEMM P, Hoffmann J, Asendorf T, Aykara I, et al
     Whole-body cryotherapy for the treatment of rheumatoid arthritis: a monocentric, single-blinded, randomised controlled trial.
     Clin Exp Rheumatol. 2022 Mar 1. pii: 17706.
     PubMed     Abstract available
     
     
     
126. PETRELLI F, Mariani FM, Alunno A, Puxeddu I, et al
     Pathogenesis of rheumatoid arthritis: one year in review 2022.
     Clin Exp Rheumatol. 2022;40:475-482.
     PubMed     Abstract available
     
     
     
127. HUANG T, Li Y, Luo Y, Zhou Y, et al
     Research progress on the pathogenesis and quality of life of patients with primary Sjogren's syndrome complicated by depression.
     Clin Exp Rheumatol. 2022;40:647-654.
     PubMed     Abstract available
     
     
     February 2022
128. VERHOEVEN MMA, Westgeest AAA, Tekstra J, van Laar JM, et al
     Classification of rheumatoid arthritis into active or inactive with a modified Disease Activity score, for future use as a treat-to-target tool, with a HandScan score replacing joint counts.
     Clin Exp Rheumatol. 2022 Feb 17. pii: 17657.
     PubMed     Abstract available
     
     
     
129. KANG JH, Choi SE, Xu H, Park DJ, et al
     Non-adherence to methotrexate was associated with high disease activity and poor health-related outcomes during a 4-year follow-up of rheumatoid arthritis patients.
     Clin Exp Rheumatol. 2022 Feb 17. pii: 17574.
     PubMed     Abstract available
     
     
     
130. NODA K, Saitou M, Matsushita T, Ukichi T, et al
     How do central sensitisation features affect symptoms among patients with rheumatoid arthritis? Analysis of pain descriptors and the effect of central sensitivity syndrome on patient and evaluator global assessments.
     Clin Exp Rheumatol. 2022 Feb 1. pii: 17676.
     PubMed     Abstract available
     
     
     
131. WU B, Peng R, Chen Y, Zhong J, et al
     Identification of RRM2 in peripheral blood mononuclear cells as a novel biomarker for the diagnosis of rheumatoid arthritis.
     Clin Exp Rheumatol. 2022 Feb 1. pii: 17730.
     PubMed     Abstract available
     
     
     
132. MURRAY MT, Penney SP, Landman A, Elias J, et al
     User experience with a voice-enabled smartphone app to collect patient-reported outcomes in rheumatoid arthritis.
     Clin Exp Rheumatol. 2022 Feb 1. pii: 16841.
     PubMed     Abstract available
     
     
     January 2022
133. HIROHATA S, Nagai T, Tomita T
     Enhanced expression of mRNA for transforming growth factor beta activated kinase 1 in CD34+ cells of the bone marrow in rheumatoid arthritis.
     Clin Exp Rheumatol. 2022 Jan 27. pii: 17941.
     PubMed     Abstract available
     
     
     
134. MASNERI S, Piantoni S, Galoppini G, Regola F, et al
     CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept.
     Clin Exp Rheumatol. 2022 Jan 27. pii: 17712.
     PubMed     Abstract available
     
     
     
135. KALYONCU U, Bilgin E, Erden A, Satis H, et al
     Efficacy and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data.
     Clin Exp Rheumatol. 2022 Jan 25. pii: 17973.
     PubMed     Abstract available
     
     
     
136. TAKASHIMA Y, Hayashi S, Maeda T, Fukuda K, et al
     Histopathological changes of synovial tissue in rheumatoid arthritis patients treated with TNF-alpha inhibitors or IL-6 inhibitors.
     Clin Exp Rheumatol. 2022 Jan 25. pii: 17785.
     PubMed     Abstract available
     
     
     
137. SMITH ID, Lu N, Wei J, Zhang Y, et al
     Alcohol consumption and the risk of mortality and myocardial infarction in patients with rheumatoid arthritis.
     Clin Exp Rheumatol. 2022 Jan 25. pii: 17761.
     PubMed     Abstract available
     
     
     
138. FORNARO M, Benaglio F, Montecucco C, Raffeiner B, et al
     Adherence of Italian rheumatologists to the EULAR recommendations and outcomes in early rheumatoid arthritis patients after starting conventional DMARDs: Methotrexate in Italian patients wiTh Rheumatoid Arthritis (the MITRA study). A cohort study of t
     Clin Exp Rheumatol. 2022 Jan 12. pii: 17698.
     PubMed     Abstract available
     
     
     
139. NOVELLA-NAVARRO M, Genre F, Hernandez-Breijo B, Remuzgo-Martinez S, et al
     Obesity and response to biological therapy in rheumatoid arthritis: the role of body mass index and adipose tissue cytokines.
     Clin Exp Rheumatol. 2022 Jan 12. pii: 17782.
     PubMed     Abstract available
     
     
     
140. MYACHIKOVA V, Moiseeva O, Konradi A, Lapin SV, et al
     A retrospective analysis of colchicine in combination with NSAIDs therapy in patients with systemic form of adult-onset Still's disease with serositis.
     Clin Exp Rheumatol. 2022 Jan 12. pii: 17765.
     PubMed     Abstract available
     
     
     
141. ISSA SF, Lindegaard HM, Lorenzen T, Junker K, et al
     Erratum corrige: Increased serum levels of microfibrillar-associated protein 4 (MFAP4) are not associated with clinical synovitis in rheumatoid arthritis but may reflect underlying cardiovascular comorbidity.
     Clin Exp Rheumatol. 2022;40:198.
     PubMed    
     
     
     December 2021
142. PODGORSKA D, Ciesla M, Majdan M, Podgorski R, et al
     The relationship of ADAMTSL2 and LRPAP1 gene methylation level with rheumatoid arthritis activity.
     Clin Exp Rheumatol. 2021 Dec 22. pii: 17757.
     PubMed     Abstract available
     
     
     November 2021
143. MODARRESI CHAHARDEHI A, Masoumi SA, Bigdeloo M, Arsad H, et al
     The effect of exercise on patients with rheumatoid arthritis on the modulation of inflammation.
     Clin Exp Rheumatol. 2021 Nov 23. pii: 17457.
     PubMed     Abstract available
     
     
     
144. SPECKER C, Aringer M, Burmester GR, Killy B, et al
     The safety and effectiveness of tocilizumab in elderly patients with rheumatoid arthritis and in patients with comorbidities associated with age.
     Clin Exp Rheumatol. 2021 Nov 22. pii: 17272.
     PubMed     Abstract available
     
     
     
145. LAYEGH Z, Hooijberg F, Bastida C, Huitema ADR, et al
     Is there a potential for therapeutic drug monitoring of subcutaneously administered tocilizumab in patients with rheumatoid arthritis in daily practice?
     Clin Exp Rheumatol. 2021 Nov 3. pii: 17173.
     PubMed    
     
     
     
146. SUGAWARA M, Fujieda Y, Noguchi A, Tanimura S, et al
     Prediction of the intolerance or non-responder to Janus kinase inhibitors in patients with rheumatoid arthritis: a preliminary retrospective study with integrative cluster analysis.
     Clin Exp Rheumatol. 2021 Nov 3. pii: 17548.
     PubMed     Abstract available
     
     
     
147. ALDRIDGE J, Lundell AC, Andersson K, Mark L, et al
     Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Nov 3. pii: 17505.
     PubMed     Abstract available
     
     
     
148. BEN-CHETRIT E, Ben-Chetrit E
     Palindromic rheumatism following COVID-19 infection evolved to rheumatoid arthritis after COVID-19 reinfection.
     Clin Exp Rheumatol. 2021;39:1410-1412.
     PubMed     Abstract available
     
     
     
149. CHOWDHURY F, Grigoriadou S, Bombardieri M
     Severity of COVID-19 infection in primary Sjogren's syndrome and the emerging evidence of COVID-19-induced xerostomia.
     Clin Exp Rheumatol. 2021;39 Suppl 133:215-222.
     PubMed     Abstract available
     
     
     
150. RETAMOZO S, Acar-Denizli N, Horvath IF, Ng WF, et al
     Influence of the age at diagnosis in the disease expression of primary Sjogren syndrome. Analysis of 12,753 patients from the Sjogren Big Data Consortium.
     Clin Exp Rheumatol. 2021;39 Suppl 133:166-174.
     PubMed     Abstract available
     
     
     
151. DUBOST JJ, Couderc M, Pereira B, Mariette X, et al
     Concomitant fibromyalgia in primary Sjogren's syndrome in the French ASSESS cohort: comparison of the ACR 1990 and ACR 2016 criteria, FiRST questionnaire and physician's opinion.
     Clin Exp Rheumatol. 2021;39 Suppl 133:140-145.
     PubMed     Abstract available
     
     
     
152. LOUREIRO-AMIGO J, Franco-Jarava C, Perurena-Prieto J, Palacio C, et al
     Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:131-139.
     PubMed     Abstract available
     
     
     
153. CAFARO G, Bursi R, Chatzis LG, Fulvio G, et al
     One year in review 2021: Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:3-13.
     PubMed     Abstract available
     
     
     
154. SISO-ALMIRALL A, Meijer JM, Brito-Zeron P, Conangla L, et al
     Practical guidelines for the early diagnosis of Sjogren's syndrome in primary healthcare.
     Clin Exp Rheumatol. 2021;39 Suppl 133:197-205.
     PubMed     Abstract available
     
     
     
155. CARUBBI F, Alunno A, Mai F, Mercuri A, et al
     Adherence to the Mediterranean diet and the impact on clinical features in primary Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:190-196.
     PubMed     Abstract available
     
     
     
156. SEGHIERI C, Lupi E, Tzioufas AG, De Vita S, et al
     Patient-reported experience and health-related quality of life in patients with primary Sjogren's syndrome in Europe.
     Clin Exp Rheumatol. 2021;39 Suppl 133:123-130.
     PubMed     Abstract available
     
     
     
157. BRITO-ZERON P, Acar-Denizli N, Romao VC, Armagan B, et al
     Post-COVID-19 syndrome in patients with primary Sjogren's syndrome after acute SARS-CoV-2 infection.
     Clin Exp Rheumatol. 2021;39 Suppl 133:57-65.
     PubMed     Abstract available
     
     
     
158. KOH JH, Park Y, Lee J, Park SH, et al
     Hypergammaglobulinaemia predicts glandular and extra-glandular damage in primary Sjogren's syndrome: results from the KISS cohort study.
     Clin Exp Rheumatol. 2021;39 Suppl 133:114-122.
     PubMed     Abstract available
     
     
     
159. LEGGER GE, Erdtsieck MB, de Wolff L, Stel AJ, et al
     Differences in presentation between paediatric- and adult-onset primary Sjogren's syndrome patients.
     Clin Exp Rheumatol. 2021;39 Suppl 133:85-92.
     PubMed     Abstract available
     
     
     
160. ZHANG X, Zhang S, Feng R, Yao H, et al
     Sonoelastography of salivary glands for diagnosis and clinical evaluation in primary Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:184-189.
     PubMed     Abstract available
     
     
     
161. DE WOLFF L, Arends S, Pontarini E, Bombardieri M, et al
     Development and performance of the Clinical Trials ESSDAI (ClinTrialsESSDAI), consisting of frequently active clinical domains, in two randomised controlled trials in primary Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:100-106.
     PubMed     Abstract available
     
     
     
162. BEJARANO MV, Romanini F, Catalan Pellet A, Mamani MN, et al
     Work productivity and activity impairment in patients with primary Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:93-99.
     PubMed     Abstract available
     
     
     
163. CHATZIS LG, Goules AV, Tzioufas AG
     Searching for the "X factor" in Sjogren's syndrome female predilection.
     Clin Exp Rheumatol. 2021;39 Suppl 133:206-214.
     PubMed     Abstract available
     
     
     
164. LORENZON M, Tulipano Di Franco F, Zabotti A, Pegolo E, et al
     Sonographic features of lymphoma of the major salivary glands diagnosed with ultrasound-guided core needle biopsy in Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:175-183.
     PubMed     Abstract available
     
     
     
165. FARENHORST CA, de Wolff L, Arends S, van Nimwegen JF, et al
     Clinical determinants of vaginal dryness in patients with primary Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:73-79.
     PubMed     Abstract available
     
     
     
166. PRINGLE SA, Berkhof B, van Ginkel M, Liefers S, et al
     Parotid salivary sodium levels of Sjogren's syndrome patients suggest B-cell mediated epithelial sodium channel disruption.
     Clin Exp Rheumatol. 2021;39 Suppl 133:30-38.
     PubMed     Abstract available
     
     
     
167. CHATZIS LG, Pezoulas V, Voulgari PV, Baldini C, et al
     Combined seronegativity in Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:80-84.
     PubMed     Abstract available
     
     
     
168. GOZUKUCUK M, Turkyilmaz E, Kucuksahin O, Erten S, et al
     Effects of primary Sjogren's syndrome on female genitalia and sexual functions.
     Clin Exp Rheumatol. 2021;39 Suppl 133:66-72.
     PubMed     Abstract available
     
     
     
169. PENG X, Lu Y, Wei J, Lin T, et al
     A cohort study of T helper 17 cell-related cytokine levels in tear samples of systemic lupus erythematosus and Sjogren's syndrome patients with dry eye disease.
     Clin Exp Rheumatol. 2021;39 Suppl 133:159-165.
     PubMed     Abstract available
     
     
     
170. COLEBY R, Lucchesi D, Pontarini E, Pitzalis C, et al
     Stepwise changes in the murine salivary gland immune response during virally-induced ectopic lymphoid structure formation.
     Clin Exp Rheumatol. 2021;39 Suppl 133:39-48.
     PubMed     Abstract available
     
     
     
171. HERNANDEZ-MOLINA G, Soto-Abraham V, Zamora-Legoff V, Furuzawa-Carballeda J, et al
     Differential Th follicular cell subsets in minor salivary glands of patients with primary Sjogren's syndrome and systemic lupus erythematosus associated with Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:49-56.
     PubMed     Abstract available
     
     
     
172. RAMOS-CASALS M, Sainz-de-la-Maza M, Muxi A
     COVID-19 vaccination unveiling subclinical Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:228-229.
     PubMed    
     
     
     
173. XU T, Guo Y, Lu J, Shan J, et al
     Untargeted serum metabolomics and potential biomarkers for Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:23-29.
     PubMed     Abstract available
     
     
     
174. SANDOVAL-FLORES MG, Chan-Campos I, Hernandez-Molina G
     Factors influencing the EULAR Sjogren's Syndrome Patient-Reported Index in primary Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:153-158.
     PubMed     Abstract available
     
     
     
175. KOMORI K, Komori M, Horino T, Nishiyama S, et al
     Factors associated with delayed diagnosis of Sjogren's syndrome among members of the Japanese Sjogren's Association for Patients.
     Clin Exp Rheumatol. 2021;39 Suppl 133:146-152.
     PubMed     Abstract available
     
     
     
176. GUNDOGUS B, Yildiz T, Agca M, Erdagi A, et al
     Sjogren's syndrome and pulmonary alveolar proteinosis co-existence.
     Clin Exp Rheumatol. 2021;39 Suppl 133:230.
     PubMed    
     
     
     
177. LANG J, Shi X, Ma Y, Zou L, et al
     Primary Sjogren's syndrome with minimal change disease: case series and literature review.
     Clin Exp Rheumatol. 2021;39 Suppl 133:226-227.
     PubMed    
     
     
     
178. JAGER-WITTENAAR H, Vissink A, Kroese FGM, Bootsma H, et al
     Undernutrition and sarcopenic obesity: underrecognised conditions in patients with Sjogren's syndrome?
     Clin Exp Rheumatol. 2021;39 Suppl 133:20-22.
     PubMed    
     
     
     
179. VIEIRA A, Grosjean A, Stone L, Oosterbaan M, et al
     Sjogren's: the European patients' community perspective.
     Clin Exp Rheumatol. 2021;39 Suppl 133:14-16.
     PubMed    
     
     
     
180. GENET L, Jalladaud M, Seror R, Gosset M, et al
     Plasma cell gingivitis, an underestimated condition in patients with Sjogren's syndrome?
     Clin Exp Rheumatol. 2021;39 Suppl 133:225.
     PubMed    
     
     
     
181. IZUKA S, Yamashita H, Takahashi Y, Kaneko H, et al
     Type II cryoglobulinaemic vasculitis with primary Sjogren's syndrome successfully treated with belimumab and hydroxychloroquine.
     Clin Exp Rheumatol. 2021;39 Suppl 133:223-224.
     PubMed    
     
     
     October 2021
182. CAFARO G, Perricone C, Riccucci I, Bursi R, et al
     Traditional and disease-related non-computed variables affect algorithms for cardiovascular risk estimation in Sjogren's syndrome and rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Oct 18. pii: 17870.
     PubMed     Abstract available
     
     
     September 2021
183. KLEMM P, Preusler P, Hudowenz O, Asendorf T, et al
     Effects of multimodal rheumatologic complex treatment in patients with rheumatoid arthritis: a monocentric prospective study.
     Clin Exp Rheumatol. 2021 Sep 28. pii: 17318.
     PubMed     Abstract available
     
     
     
184. THOMPSON AE, Pope JE
     The erratic C-reactive protein: a novel outcome measure for longitudinal disease activity in rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Sep 21. pii: 17449.
     PubMed     Abstract available
     
     
     
185. RODRIGUEZ-MUGURUZA S, Combe B, Guillemin F, Fautrel B, et al
     Trajectories in early rheumatoid arthritis related fatigue over 10 years: results from the ESPOIR cohort.
     Clin Exp Rheumatol. 2021 Sep 21. pii: 17302.
     PubMed     Abstract available
     
     
     
186. ZHENG B, Soares de Moura C, Machado M, Pineau CA, et al
     Association between chronic obstructive pulmonary disease, smoking, and interstitial lung disease onset in rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Sep 7. pii: 17256.
     PubMed     Abstract available
     
     
     
187. PERNIOLA S, Bizzoca R, Fornaro M, Alivernini S, et al
     High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study.
     Clin Exp Rheumatol. 2021 Sep 7. pii: 16999.
     PubMed     Abstract available
     
     
     
188. DURAN E, Yildirim BES, Karadag O
     Comment on: Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis by Humby et al.
     Clin Exp Rheumatol. 2021 Sep 7. pii: 17387.
     PubMed    
     
     
     
189. MARIOTTE A, Bernardi L, Macquin C, DeCauwer A, et al
     NKG2D ligands in inflammatory joint diseases: analysis in human samples and mouse models.
     Clin Exp Rheumatol. 2021;39:982-987.
     PubMed     Abstract available
     
     
     
190. YAO H, Wang Y, Wang Z, Zhao J, et al
     The performance of the diagnostic scoring system or criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis for adult-onset Still's disease. A multicentre case-control study in China.
     Clin Exp Rheumatol. 2021;39 Suppl 132:129-134.
     PubMed     Abstract available
     
     
     
191. YANG CA, Chen PK, Lan JL, Chang CK, et al
     Expression signature of inflammation-associated long non-coding RNAs in adult-onset Still's disease.
     Clin Exp Rheumatol. 2021;39 Suppl 132:67-74.
     PubMed     Abstract available
     
     
     
192. GAO Q, Yuan Y, Wang Y, Jiang J, et al
     Clinical characteristics of macrophage activation syndrome in adult-onset Still's disease.
     Clin Exp Rheumatol. 2021;39 Suppl 132:59-66.
     PubMed     Abstract available
     
     
     
193. AIZAKI Y, Yazawa H, Sato K, Mimura T, et al
     Dual effects of interleukin-10 on natural killer cells and monocytes and the implications for adult-onset Still's disease.
     Clin Exp Rheumatol. 2021;39 Suppl 132:22-29.
     PubMed     Abstract available
     
     
     
194. YAMAMOTO S, Nishimura K, Yo K, Waki D, et al
     Flare-up of adult-onset Still's disease after receiving a second dose of BNT162b2 COVID-19 mRNA vaccine.
     Clin Exp Rheumatol. 2021;39 Suppl 132:139-140.
     PubMed    
     
     
     August 2021
195. KITAMURA N, Sugiyama K, Nagasawa Y, Hamaguchi M, et al
     Involvement of Epstein-Barr virus in the development and spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Aug 5. pii: 17140.
     PubMed     Abstract available
     
     
     July 2021
196. CIESLA M, Kolarz B, Majdan M, Darmochwal-Kolarz D, et al
     Plasma micro-RNA-22 is associated with disease activity in well-established rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Jul 24. pii: 16995.
     PubMed     Abstract available
     
     
     
197. LEE K, Min HK, Koh SH, Lee SH, et al
     Prognostic signature of interferon-gamma and interleurkin-17A in early rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Jul 23. pii: 17190.
     PubMed     Abstract available
     
     
     
198. YOSHIZAWA Y, Nakao T, Tsuritani K, Yamada T, et al
     The importance of specific citrullinated clusterin and vimentin found in a multi-coloured bead-based citrulline-peptide array system in rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Jul 8. pii: 16877.
     PubMed     Abstract available
     
     
     
199. PULITO-CUETO V, Remuzgo-Martinez S, Genre F, Calvo-Alen J, et al
     Role of adiponectin in non-diabetic patients with rheumatoid arthritis undergoing anti-IL-6 therapy.
     Clin Exp Rheumatol. 2021 Jul 7. pii: 17208.
     PubMed     Abstract available
     
     
     
200. MATSUNO H, Kang YM, Okada M, Lee SI, et al
     Comparison of the efficacy and safety of LBAL, a candidate adalimumab biosimilar, and adalimumab reference product in patients with active rheumatoid arthritis inadequately responding to methotrexate: a 52-week phase III randomised study.
     Clin Exp Rheumatol. 2021 Jul 7. pii: 16868.
     PubMed     Abstract available
     
     
     
201. SILVAGNI E, Sakellariou G, Bortoluzzi A, Giollo A, et al
     One year in review 2021: novelties in the treatment of rheumatoid arthritis.
     Clin Exp Rheumatol. 2021;39:705-720.
     PubMed     Abstract available
     
     
     
202. MONA M, Mondello S, Hyon JY, Saleh W, et al
     Clinical usefulness of anti-muscarinic type 3 receptor autoantibodies in patients with primary Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39:795-803.
     PubMed     Abstract available
     
     
     
203. LORAND V, Nagy G, Balint Z, Komjati D, et al
     Sensitivity to change of joint count composite indices in 72 patients with systemic sclerosis.
     Clin Exp Rheumatol. 2021;39 Suppl 131:77-84.
     PubMed     Abstract available
     
     
     June 2021
204. ALVARO GRACIA JM, Barbazan C, Garcia Llorente JF, Munoz-Fernandez S, et al
     Local adaptation of recommendation-based materials for shared decision-making and management of comorbidity in rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Jun 26. pii: 17046.
     PubMed     Abstract available
     
     
     
205. CACCIAPAGLIA F, Renna D, Fornaro M, Venerito V, et al
     Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre.
     Clin Exp Rheumatol. 2021 Jun 25. pii: 16172.
     PubMed    
     
     
     
206. BOLETO G, Cren JB, Avouac J, Allanore Y, et al
     Successful treatment with baricitinib of refractory arthritis in a patient with severe diffuse cutaneous systemic sclerosis-rheumatoid arthritis overlap syndrome.
     Clin Exp Rheumatol. 2021 Jun 15. pii: 17277.
     PubMed    
     
     
     
207. PIARULLI A, Conversano C, Ciacchini R, Miniati M, et al
     Catastrophisation, chronic pain and sexuality: a cross-sectional investigation in fibromyalgia and rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Jun 10. pii: 17303.
     PubMed     Abstract available
     
     
     
208. SAITOU M, Noda K, Matsushita T, Ukichi T, et al
     Central sensitisation features are associated with neuropathic pain-like symptoms in patients with longstanding rheumatoid arthritis: a cross-sectional study using the central sensitisation inventory.
     Clin Exp Rheumatol. 2021 Jun 8. pii: 17108.
     PubMed     Abstract available
     
     
     
209. RAMIREZ J, Azuaga-Pinango AB, Frade-Sosa B, Gumucio-Sanguino R, et al
     Proliferative synovitis, an ultrasound pattern associated with ACPA-positive patients and erosive disease in rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Jun 8. pii: 16966.
     PubMed     Abstract available
     
     
     May 2021
210. WINTHROP KL, Tanaka Y, Lee EB, Wollenhaupt J, et al
     Prevention and management of herpes zoster in patients with rheumatoid arthritis and psoriatic arthritis: a clinical review.
     Clin Exp Rheumatol. 2021 May 28. pii: 16343.
     PubMed     Abstract available
     
     
     
211. BEHRENS F, Burmester GR, Feuchtenberger M, Kellner H, et al
     Characterisation of depressive symptoms in rheumatoid arthritis patients treated with tocilizumab during routine daily care.
     Clin Exp Rheumatol. 2021 May 14. pii: 16554.
     PubMed     Abstract available
     
     
     
212. THALMANN R, von Kempis J, Zgraggen A, Graf N, et al
     Analysis of patients with rheumatoid arthritis and higher radiographic progression: association of very high radiographic progression but not of intermediately high worsening of patient-related outcomes.
     Clin Exp Rheumatol. 2021 May 5. pii: 16889.
     PubMed     Abstract available
     
     
     
213. TESTA D, Calvacchi S, Petrelli F, Giannini D, et al
     One year in review 2021: pathogenesis of rheumatoid arthritis.
     Clin Exp Rheumatol. 2021;39:445-452.
     PubMed     Abstract available
     
     
     
214. KONDO Y, Kaneko Y, Takei H, Tamai H, et al
     COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult Still's disease.
     Clin Exp Rheumatol. 2021;39:631-638.
     PubMed     Abstract available
     
     
     
215. DITTO MC, Parisi S, Varisco V, Talotta R, et al
     Prevalence of hepatitis B virus infection and risk of reactivation in rheumatic population undergoing biological therapy.
     Clin Exp Rheumatol. 2021;39:546-554.
     PubMed     Abstract available
     
     
     
216. IANNUCCELLI C, Lucchino B, Gioia C, Dolcini G, et al
     Mental health and well-being during the COVID-19 pandemic: stress vulnerability, resilience and mood disturbances in fibromyalgia and rheumatoid arthritis.
     Clin Exp Rheumatol. 2021;39 Suppl 130:153-160.
     PubMed     Abstract available
     
     
     
217. ALMIRALL M, Martinez-Mateu SH, Alegre C, Collado A, et al
     Dietary habits in patients with fibromyalgia: a cross-sectional study.
     Clin Exp Rheumatol. 2021;39 Suppl 130:170-173.
     PubMed     Abstract available
     
     
     April 2021
218. RETUERTO M, Trujillo E, Valero C, Fernandez-Espartero C, et al
     Efficacy and safety of switching Jak inhibitors in rheumatoid arthritis: an observational study.
     Clin Exp Rheumatol. 2021 Apr 27. pii: 17091.
     PubMed     Abstract available
     
     
     
219. AVOUAC J, Degrave R, Vergneault H, Combier A, et al
     Risk of liver fibrosis induced by methotrexate and other rheumatoid arthritis medications according to the Fibrosis-4 Index.
     Clin Exp Rheumatol. 2021 Apr 23. pii: 16697.
     PubMed     Abstract available
     
     
     
220. DI CARLO M, Tardella M, Filippucci E, Carotti M, et al
     Lung ultrasound in patients with rheumatoid arthritis: definition of significant interstitial lung disease.
     Clin Exp Rheumatol. 2021 Apr 23. pii: 16655.
     PubMed     Abstract available
     
     
     March 2021
221. PERTSINIDOU E, Manivel VA, Westerlind H, Klareskog L, et al
     Rheumatoid arthritis autoantibodies and their association with age and sex.
     Clin Exp Rheumatol. 2021 Mar 30. pii: 16843.
     PubMed     Abstract available
     
     
     
222. HASSELI R, Pfeil A, Hoyer BF, Krause A, et al
     Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis?
     Clin Exp Rheumatol. 2021 Mar 30. pii: 16822.
     PubMed     Abstract available
     
     
     
223. PATLAN M, Paez A, Masso F, Amezcua-Guerra LM, et al
     Relative increase of Th17 phenotype in senescent CD4+CD28null T cells from peripheral blood of patients with rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Mar 30. pii: 16892.
     PubMed    
     
     
     
224. ZHAO X, Gan Y, Jin Y, He J, et al
     Interleukin 17E associates with haematologic involvement and autoantibody production in primary Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39:378-384.
     PubMed     Abstract available
     
     
     
225. CAMPOCHIARO C, Tomelleri A, Galli E, Cocchiara E, et al
     Failure of first anti-TNF agent in Takayasu's arteritis: to switch or to swap?
     Clin Exp Rheumatol. 2021;39 Suppl 129:129-134.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: